Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

IMPORTANCE: Anti-vascular endothelial growth factor (anti-VEGF) therapy for diabetic macular edema (DME) favorably affects diabetic retinopathy (DR) improvement and worsening. It is unknown whether these effects differ across anti-VEGF agents. OBJECTIVE: To compare changes in DR severity during afli...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:JAMA Ophthalmol
Prif Awduron: Bressler, Susan B., Liu, Danni, Glassman, Adam R., Blodi, Barbara A., Castellarin, Alessandro A., Jampol, Lee M., Kaufman, Paul L., Melia, Michele, Singh, Harinderjit, Wells, John A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Medical Association 2017
Pynciau:
Original Investigation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540030/
https://ncbi.nlm.nih.gov/pubmed/28448655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2017.0821
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg